Tag: pharmacogenetic testing market size

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Pharmacogenetic Testing Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_

The pharmacogenetic testing market has experienced substantial expansion in recent years. Its valuation is projected to grow from $14.33 billion in 2025 to $16.58 billion in 2026, at a compound annual growth rate (CAGR) of 15.7%. The market’s historical growth can be attributed to advancements in genomic sequencing technologies, concerns regarding adverse drug reactions, the increasing burden of chronic diseases, declining genetic testing costs, and a rise in clinical awareness._x000D_

_x000D_

The pharmacogenetic testing market size is anticipated to undergo substantial growth over the next few years, with projections indicating it will reach $29.55 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.5%. This expansion during the forecast period is primarily driven by factors such as the advancement of precision healthcare, the broadening availability of direct-to-consumer testing, enhanced integration with electronic health records, increasing regulatory support, and greater investment in genomics research. Additionally, significant trends expected during this period include a rising adoption of personalized medicine, a more widespread use of genetic testing in drug selection, an expansion of its applications in oncology and cardiology, a growing demand for precision diagnostics, and the integration of pharmacogenomics into routine clinical practice._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=89547410&type=smp&name=Pharmacogenetic%20Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmacogenetic Testing Market Growth Drivers: What’s Behind The Acceleration?#_x000D_

The future growth of the pharmacogenetic testing market is anticipated to be boosted by the escalating need for personalized medicine. Personalized medicine, also known as precision medicine, is a healthcare strategy that customizes treatments and medical choices based on a person’s distinct genetic makeup, biological traits, and lifestyle. The heightened call for personalized medicine stems from its capacity to enhance treatment efficacy, facilitate early diagnosis, and improve cost efficiency in patient care. The pharmacogenetic testing market facilitates personalized medicine by examining an individual’s genetic profile to forecast drug reactions, thereby allowing for better treatment choices and minimizing the likelihood of negative side effects. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 approvals in 2022. Consequently, the rising demand for personalized medicine is fueling the expansion of the pharmacogenetic testing market._x000D_

_x000D_

#Pharmacogenetic Testing Market Segment Landscape: Which Areas Lead Development?#_x000D_

The pharmacogenetic testing market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests_x000D_

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications_x000D_

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas_x000D_

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services_x000D_

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing_x000D_

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing_x000D_

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing_x000D_

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes_x000D_

_x000D_

#Pharmacogenetic Testing Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_

Key companies within the pharmacogenetics testing market are prioritizing the creation of advanced pharmacogenomics testing services, including prescription-based pharmacogenetic testing, to improve medication safety, enhance treatment precision, and support personalized therapeutic decision-making. Prescription-based pharmacogenetic testing involves genetic analyses initiated by licensed healthcare providers to investigate how an individual’s genetic composition influences their response to specific medications, thus empowering clinicians to optimize drug selection and dosing while mitigating the probability of adverse drug reactions. For instance, in May 2023, UCSF, a US-based healthcare organization, unveiled its pharmacogenomics testing service, which was designed to elevate the precision of medical treatments. This service equips healthcare professionals with genetic insights that aid in tailoring drug therapies to each patient’s unique profile, thereby strengthening drug efficacy and minimizing the risk of harmful side effects._x000D_

_x000D_

#Pharmacogenetic Testing Market Industry Leaders And Competitive Landscape#_x000D_

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC _x000D_

_x000D_

#View The Full Pharmacogenetic Testing Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmacogenetic Testing Market Geographic Analysis: Where Is Demand Rising Fastest?#_x000D_

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Pharmacogenetic Testing Market Expected To Reach $29.54 Billion By 2030 At 15.5% CAGR

The pharmacogenetic testing sector has experienced significant expansion in recent years, with its market value projected to rise from $14.33 billion in 2025 to $16.58 billion in 2026, reflecting a compound annual growth rate of 15.7%. Key drivers behind this historical growth include improvements in genomic sequencing techniques, heightened awareness regarding adverse drug reactions, an increasing prevalence of chronic diseases, reduced expenses associated with genetic testing, and a growing understanding of clinical applications.

The pharmacogenetic testing market is projected to expand significantly in the coming years. By 2030, its value is anticipated to reach $29.55 billion, representing a compound annual growth rate (CAGR) of 15.5%. This anticipated expansion is fueled by developments such as the advancement of precision healthcare, the broadening of direct-to-consumer testing services, the incorporation of data into electronic health records, heightened regulatory backing, and increased funding for genomics research. Key trends shaping the forecast period encompass a growing embrace of personalized medicine, more frequent use of genetic assessments to inform drug choices, extended applications in oncology and cardiology, heightened demand for precise diagnostic tools, and the broader integration of pharmacogenomics into routine medical practice.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmacogenetic Testing Market Development Factors: Which Trends Are Supporting Demand?

The rising need for tailored medical approaches is anticipated to boost the pharmacogenomic testing industry moving forward. Personalized or precision medicine involves a healthcare strategy that customizes treatments and medical choices based on an individual’s distinct genetic, biological, and lifestyle factors. This approach is gaining traction because it enhances therapeutic results, aids in early diagnosis, and improves cost efficiency in patient management. The pharmacogenomic testing sector facilitates personalized medicine by examining a person’s genetic makeup to forecast drug reactions, allowing for refined therapy choices and lowering the chance of harmful side effects. As an example, in February 2024, the Personalized Medicine Coalition (PMC), a non-profit organization in the U.S., reported that the FDA authorized 16 novel personalized therapies for uncommon diseases in 2023, up from 6 approvals in 2022. Consequently, the growing uptake of personalized medicine is fueling the expansion of the pharmacogenomic testing market.

Pharmacogenetic Testing Market Segment Outlook: Which Categories Are Expanding The Fastest?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Pharmacogenetic Testing Market Transformation Trends: Which Innovations Are Driving Change?

Leading players in the pharmacogenetics testing market are prioritizing the creation of sophisticated pharmacogenomics services, like prescription-based tests, aimed at boosting medication safety, refining treatment accuracy, and aiding personalized therapy choices. This type of testing involves genetic assessments requested by authorized medical professionals to determine how a person’s genetic profile impacts their reaction to particular drugs, enabling practitioners to enhance drug selection and dosage while cutting down the chance of adverse events. A notable example from May 2023 is UCSF, a healthcare organization based in the United States, which introduced its pharmacogenomics testing service to advance the precision of medical care, offering clinicians genetic data that facilitates tailoring drug regimens to each patient’s individual characteristics, improves drug effectiveness, and lowers the potential for serious side effects.

Pharmacogenetic Testing Market Key Companies And Competitive Benchmarking

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Access The Complete Pharmacogenetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmacogenetic Testing Market Leading Geography: Which Region Generates The Most Revenue?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Pharmacogenetic Testing Market By 2030?

The pharmacogenetic testing market has shown considerable expansion in recent times. It is anticipated to expand from $14.33 billion in 2025 to $16.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.7%. The surge observed in the past period stems from improvements in genomic sequencing technologies, worries regarding adverse drug reactions, an escalating burden of chronic diseases, decreasing genetic testing expenses, and heightened clinical recognition.

The pharmacogenetic testing market is projected to experience significant expansion in the coming years. This market is predicted to reach a value of $29.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. This anticipated growth during the forecast period is driven by several factors, including the advancement of precision healthcare, the wider availability of direct-to-consumer testing, the incorporation with electronic health records, growing regulatory backing, and increased funding in genomics research. Key trends anticipated for the same period encompass the increasing acceptance of personalized medicine, a greater reliance on genetic testing for drug selection, the broadening of applications in oncology and cardiology, a surging need for precision diagnostics, and the incorporation of pharmacogenomics into routine clinical practice.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Influential Factors Are Boosting The Pharmacogenetic Testing Market Demand?

The future expansion of the pharmacogenetic testing market is anticipated, driven by the increasing need for personalized medicine. This healthcare strategy, also known as precision medicine, customizes treatments and medical decisions according to an individual’s specific genetic, biological, and lifestyle characteristics. The demand for personalized medicine is on the rise because it enhances treatment outcomes, supports timely disease detection, and improves cost-effectiveness in patient care. The pharmacogenetic testing market plays a crucial role in personalized medicine by analyzing a person’s genetic profile to predict drug responses, thereby enabling optimal treatment selection and reducing the likelihood of adverse reactions. For instance, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a considerable increase from 6 approvals in 2022. Thus, the escalating demand for personalized medicine is propelling the growth of the pharmacogenetic testing market.

What Key Segment Areas Are Included In The Pharmacogenetic Testing Market Assessment?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Which Trends Are Influencing The Expansion Of The Pharmacogenetic Testing Market?

Key companies operating within the pharmacogenetics testing market are concentrating on the development of advanced pharmacogenomics testing services, including prescription-based pharmacogenetic testing, with the aim of boosting medication safety, increasing treatment accuracy, and supporting personalized therapeutic choices. Prescription-based pharmacogenetic testing involves genetic analyses initiated by licensed healthcare providers to assess how an individual’s genetic composition affects their response to particular medications, thereby allowing clinicians to refine drug selection and dosing while mitigating the probability of adverse drug reactions. For example, in May 2023, UCSF, a US-based healthcare organization, introduced its pharmacogenomics testing service designed to enhance the precision of medical treatments, furnishing healthcare professionals with genetic data that assists in tailoring drug therapies to each patient’s distinct profile, thereby strengthening drug efficacy and reducing the potential for harmful side effects.

Who Are The Firms Contributing To The Pharmacogenetic Testing Market Ecosystem?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Access The Complete Pharmacogenetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Contributes The Most To The Pharmacogenetic Testing Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmacogenetic Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

Browse Through More Reports Similar to the Global Pharmacogenetic Testing Market 2026, By The Business Research Company

Neurogenetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Pharmacogenetic Testing Market Expected To Scale Between 2026 And 2030?

The pharmacogenetic testing market has experienced significant expansion recently. Its size is expected to increase from $14.33 billion in 2025 to $16.58 billion in 2026, registering a compound annual growth rate (CAGR) of 15.7%. Historically, this growth has been driven by progress in genomic sequencing technologies, concerns about adverse drug reactions, the escalating burden of chronic diseases, falling genetic testing costs, and greater clinical awareness.

The pharmacogenetic testing market size is expected to experience significant expansion in the next few years. It is projected to reach $29.55 billion in 2030, with a compound annual growth rate (CAGR) of 15.5%. The expansion during the forecast period is largely attributable to the advancement of precision healthcare, the widening scope of direct-to-consumer testing, better integration with electronic health records, enhanced regulatory backing, and increasing investment in genomics research. Key trends anticipated in the forecast period include the rising acceptance of personalized medicine, a greater utilization of genetic testing for drug selection, the broadening of oncology and cardiology applications, an escalating demand for precision diagnostics, and the integration of pharmacogenomics into routine clinical practice.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Key Drivers Are Fueling The Growth Of The Pharmacogenetic Testing Market?

The escalating need for personalized medicine is projected to propel the expansion of the pharmacogenetic testing market moving forward. Personalized medicine, also referred to as precision medicine, represents a healthcare approach that customizes treatments and medical decisions based on an individual’s distinct genetic, biological, and lifestyle attributes. The impetus for personalized medicine is growing because of its effectiveness in improving treatment results, aiding early diagnosis, and enhancing cost-efficiency in patient care. The pharmacogenetic testing market facilitates personalized medicine by evaluating an individual’s genetic makeup to forecast drug responses, thus enabling optimized treatment choices and lessening the likelihood of adverse reactions. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a rise from 6 approvals in 2022. As a result, the rising demand for personalized medicine is a key factor driving the growth of the pharmacogenetic testing market.

What Segment Categories Shape The Pharmacogenetic Testing Market Segment Landscape?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Emerging Trends Are Seen In The Pharmacogenetic Testing Market?

Leading companies in the pharmacogenetics testing market are concentrating on developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to boost medication safety, improve treatment precision, and support individualized therapeutic decision-making. Prescription-based pharmacogenetic testing refers to genetic analyses ordered by licensed healthcare providers to examine how an individual’s genetic makeup influences their response to specific medications, allowing clinicians to optimize drug selection and dosing while reducing the likelihood of adverse drug reactions. For instance, in May 2023, UCSF, a US-based healthcare organization, launched its pharmacogenomics testing service designed to improve the precision of medical treatments, providing healthcare professionals with genetic insights that help tailor drug therapies to each patient’s unique profile, strengthen drug efficacy, and minimize the risk of harmful side effects.

Who Are The Companies Operating Across The Pharmacogenetic Testing Market Value Chain?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Get The Full Pharmacogenetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Accounts For The Largest Portion Of The Pharmacogenetic Testing Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmacogenetic Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Browse Through More Reports Similar to the Global Pharmacogenetic Testing Market 2026, By The Business Research Company

Neurogenetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Pharmacogenetic Testing Market During The Forecast Period 2026–2030?

The pharmacogenetic testing market has shown considerable growth in recent years. This market is expected to expand from $14.33 billion in 2025 to $16.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.7%. The historical expansion can be traced to advancements in genomic sequencing technologies, concerns over adverse drug reactions, a rising incidence of chronic diseases, decreasing genetic testing costs, and improved clinical awareness.

The pharmacogenetic testing market is poised for significant expansion in the coming years. It is projected to reach $29.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. This anticipated growth throughout the forecast period stems from factors such as the development of precision healthcare, the broader availability of direct-to-consumer testing, the integration with electronic health records, increasing regulatory assistance, and heightened investment in genomics research. Prominent trends expected in this timeframe include the rising acceptance of personalized medicine, a greater application of genetic testing in selecting drugs, the expansion of oncology and cardiology uses, a growing requirement for precision diagnostics, and the routine incorporation of pharmacogenomics into clinical practice.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Underlying Factors Are Accelerating The Growth Of The Pharmacogenetic Testing Market?

The pharmacogenetic testing market is anticipated to grow, propelled by the rising demand for personalized medicine. This healthcare approach, also known as precision medicine, customizes treatments and medical decisions according to an individual’s distinct genetic, biological, and lifestyle attributes. The increasing need for personalized medicine is attributed to its ability to improve treatment results, aid in early detection, and enhance cost-effectiveness in patient care. The pharmacogenetic testing market contributes to personalized medicine by examining a person’s genetic makeup to forecast drug responses, thus facilitating optimal treatment choices and reducing the likelihood of adverse reactions. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, noted that the FDA sanctioned 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 approvals in 2022. Therefore, the escalating demand for personalized medicine is driving the expansion of the pharmacogenetic testing market.

What Market Segments Are Evaluated Within The Pharmacogenetic Testing Market?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Industry Trends Are Redefining The Pharmacogenetic Testing Market?

Leading companies within the pharmacogenetics testing market are concentrating on developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing. This initiative seeks to enhance medication safety, improve treatment precision, and support personalized therapeutic decision-making. Prescription-based pharmacogenetic testing refers to genetic analyses commissioned by licensed healthcare providers to examine how an individual’s genetic makeup influences their response to specific medications, enabling clinicians to optimize drug selection and dosing while reducing the likelihood of adverse drug reactions. For instance, in May 2023, UCSF, a US-based healthcare organization, launched its pharmacogenomics testing service. This service is designed to improve the precision of medical treatments by providing healthcare professionals with genetic insights that help tailor drug therapies to each patient’s unique profile, strengthen drug efficacy, and minimize the risk of harmful side effects.

Who Are The Top Market Participants Influencing The Pharmacogenetic Testing Market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Read the full pharmacogenetic testing market report here:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Is Projected To Dominate The Pharmacogenetic Testing Market During The Forecast Period?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmacogenetic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

Browse Through More Reports Similar to the Global Pharmacogenetic Testing Market 2026, By The Business Research Company

Neurogenetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmacogenetic testing market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Pharmacogenetic Testing Market between 2026 and 2030?

The pharmacogenetic testing market has seen rapid expansion in recent years. It is projected to grow from $14.33 billion in 2025 to $16.58 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. Historically, this market’s expansion was propelled by advancements in genomic sequencing technologies, concerns regarding adverse drug reactions, an increasing burden of chronic diseases, decreasing genetic testing expenses, and improved clinical awareness.

The pharmacogenetic testing market is projected to experience swift expansion in the coming years. Its valuation is anticipated to reach $29.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. This anticipated growth during the forecast period can be primarily attributed to factors such as the rise of precision healthcare, the broadening of direct-to-consumer testing options, the incorporation of these tests with electronic health records, augmented regulatory backing, and increased financial commitment to genomics research. Key trends projected for this period encompass the escalating acceptance of personalized medicine, the expanding application of genetic testing in choosing drugs, the widening scope of its use in oncology and cardiology, an increasing need for accurate diagnostics, and the incorporation of pharmacogenomics into routine clinical practice.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Pharmacogenetic Testing Market?

The projected expansion of the pharmacogenetic testing market is anticipated to be fueled by the growing need for personalized medicine. This approach, also known as precision medicine, involves customizing healthcare interventions and choices based on an individual’s distinct genetic makeup, biological traits, and lifestyle. Its increasing appeal stems from its capacity to enhance treatment efficacy, facilitate prompt diagnoses, and improve the economic efficiency of patient care. The pharmacogenetic testing market plays a crucial role in personalized medicine by examining genetic profiles to forecast how individuals will respond to drugs, thereby allowing for better treatment choices and minimizing the likelihood of negative side effects. As an illustration, in February 2024, data from the US-based non-profit, Personalized Medicine Coalition (PMC), indicated that the FDA cleared 16 new personalized therapies for rare disease patients in 2023, a significant rise from 6 approvals in 2022. Consequently, the escalating demand for personalized medicine serves as a key impetus for the expansion of the pharmacogenetic testing market.

How Is The Pharmacogenetic Testing Market Organized Into Various Segments?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Which Market Trends Are Opening Growth Opportunities In The Pharmacogenetic Testing Market?

Leading entities within the pharmacogenetics testing market are concentrating on creating sophisticated pharmacogenomics testing offerings, including prescription-ordered pharmacogenetic tests, with the aim of boosting medication safety, refining treatment accuracy, and facilitating individualized therapeutic choices. This type of testing, where genetic analyses are requested by qualified healthcare professionals, investigates how a person’s genetic composition impacts their reaction to particular drugs. This enables clinicians to fine-tune drug choices and dosages, thereby lessening the chance of unfavorable drug responses. As an illustration, in May 2023, UCSF, a US-based healthcare institution, introduced its pharmacogenomics testing service. This service is designed to elevate the accuracy of medical interventions by furnishing healthcare professionals with genetic data that assists in customizing drug regimens for each patient’s distinct profile, enhancing drug effectiveness, and mitigating the potential for detrimental side effects.

Who Are The Major Companies Operating In The Pharmacogenetic Testing Market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Pharmacogenetic Testing Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmacogenetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

Browse Through More Reports Similar to the Global Pharmacogenetic Testing Market 2026, By The Business Research Company

Neurogenetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pediatric vaccine market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Pediatric Vaccine Market Be Worth By 2029, And What CAGR Will It Achieve?

The pharmacogenetic testing market has experienced significant expansion in its size during recent years. It is forecast to rise from $12.37 billion in 2024 to $14.33 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.8%. This growth observed in the past can be ascribed to an increase in overall drug efficacy, the expanding acceptance of personalized medicine, a rising requirement for precise diagnoses, an enhanced focus on pharmacogenetic testing, and escalating medical expenses.

The pharmacogenetic testing market is anticipated to experience substantial growth over the next few years. It is projected to expand to $25.62 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.6%. The expansion during the forecast period is driven by increased research and development within biotechnology and healthcare, rising healthcare expenditure, a growing prevalence of chronic diseases, enhanced accessibility, and the emergence of telemedicine and digital health. Dominant trends expected in this period include developments in pharmacogenetic testing, progress in genomic technologies, general technological advancements, improvements in companion diagnostics, and the introduction of innovative diagnostic tests.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

Which Factors Are Driving The Pediatric Vaccine Market Forward?

The growing need for personalized medicine is projected to drive expansion within the pharmacogenetic testing market going forward. Also known as precision medicine, personalized medicine represents a medical strategy where healthcare choices and treatments are customized to each patient’s unique attributes. The rise of personalized medicine stems from multiple factors, including enhanced treatment results, an emphasis on disease prevention and prompt diagnosis, and its economic efficiency. Pharmacogenetic testing plays a crucial role in personalized medicine, as it examines a person’s genetic composition to forecast their reaction to particular drugs. This allows healthcare professionals to customize treatments according to genetic factors, thereby maximizing drug effectiveness and reducing unwanted side effects. For example, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in February 2024, the FDA gave approval to 16 new personalized therapies for rare disease patients in 2023, a significant increase from six in 2022. Consequently, the escalating demand for personalized medicine is a key driver for the expansion of the pharmacogenetic testing market.

Which Segments Form The Key Structure Of The Pediatric Vaccine Market?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Strategic Shifts And Innovations Are Influencing The Pediatric Vaccine Market?

Major companies within the pharmacogenetics testing market are developing sophisticated pharmacogenomics testing services, including prescription-based pharmacogenetic testing, to secure a competitive edge. Prescription-based pharmacogenetic testing refers to genetic assessments specifically ordered or prescribed by healthcare providers to analyze a patient’s genetic makeup prior to medication prescription. For instance, in May 2023, UCSF, a US-based healthcare company, introduced its pharmacogenomics testing service. This service is designed to enhance the precision of medical treatments. UCSF’s pharmacogenomics testing service assists healthcare providers in tailoring drug therapies based on an individual’s genetic profile, with the aim of boosting drug efficacy, reducing adverse reactions, and supporting personalized medicine strategies.

Which Firms Are Making The Biggest Impact In The Pediatric Vaccine Market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Is Expected To Lead The Pediatric Vaccine Market In The Next Few Years?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2025, By The Business Research Company

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Epigenetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Optogenetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Will The Pharmacogenetic Testing Market Valuation Change Between Now And 2029?

The pharmacogenetic testing market has seen substantial growth recently. It is set to expand from $12.37 billion in 2024 to $14.33 billion in 2025, marking a compound annual growth rate (CAGR) of 15.8%. The historical growth could be credited to escalating drug effectiveness, rising acceptance of individualized care, an expanding need for accurate diagnosis, an increased emphasis on pharmacogenetic testing, and growing medical costs.

Forecasts suggest a swift expansion of the pharmacogenetic testing market in the coming years. The predicted growth is valued at $25.62 billion in 2029 with a compound annual growth rate (CAGR) of 15.6%. The driving factors for this projected growth in upcoming years include enhanced research in biotechnology and health sector, increased healthcare spending, heightened instances of chronic illnesses, improved reach, growth of telemedicine, and digital health. The key trends in this period will likely encompass pharmacogenetic testing, innovation in genomic technologies, technological progression, strides in companion diagnostics, and pioneering diagnostic examinations.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

Which Key Factors Are Fueling Growth In The Pharmacogenetic Testing Market?

The growing need for individualized medical treatments is anticipated to boost the expansion of the pharmacogenetic testing market. Personalized medicine, also referred to as precision medicine, designs healthcare strategies and applications based on an individual’s unique traits. The rise in personalized medicine can be attributed to several elements, including enhanced treatment results, an emphasis on early detection and prevention, and its cost-effectiveness. Pharmacogenetic testing plays a crucial role in personalized medicine by investigating a person’s genetic profile to determine how they’ll react to certain drugs. This allows healthcare professionals to customize treatments around genetic variables, maximizing drug efficiency and reducing negative side effects. For instance, in February 2024, the Personalized Medicine Coalition, an American non-profit group, reported that the FDA approved 16 unique personalized therapies for rare disease patients in 2023, which is a considerable increase from six in 2022. Consequently, the ascending demand for personalized medicine is fueling the growth of the pharmacogenetic testing market.

How Is The Global Pharmacogenetic Testing Market Broken Down By Segment?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Which Trends Are Likely To Redefine Growth Paths In The Pharmacogenetic Testing Market?

Leading corporations in the pharmacogenetics testing market sphere are innovating and introducing sophisticated pharmacogenomics testing services like prescription-based pharmacogenetic testing, with the intent to strengthen their market position. These genetic tests, specifically requested by healthcare providers, are utilized to examine a patient’s genetic framework prior to recommending medications. In light of this, in May 2023, an American healthcare firm called UCSF initiated its own pharmacogenomics testing service to boost accuracy in medicinal treatments. Designed to assist healthcare providers in customizing drug therapies according to a person’s genetic constitution, UCSF’s pharmacogenomics testing service aims to enhance the effectiveness of medications, reduce unwanted side effects, and foster personalized medical treatment strategies.

Which Firms Are Making The Biggest Impact In The Pharmacogenetic Testing Market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Pharmacogenetic Testing Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Pediatric Vaccine Market Expected to Be in 2029?

In recent years, the market size for pharmacogenetic testing has seen significant expansion. It is projected to increase from $12.37 billion in 2024 to $14.33 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. The historic growth can be attributed to a rise in the overall efficacy of drugs, an increase in the adoption of personalized medicine, a growing demand for precision diagnosis, a heightened focus on pharmacogenetic testing, and rising medical costs.

The market size for pharmacogenetic testing is projected to experience swift expansion in the coming years, with expected growth reaching “$25.62 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%.” Factors contributing to this anticipated growth during the forecast period include the increase in biotechnology and healthcare-related research and development, higher healthcare expenditures, an uptick in chronic disease cases, enhanced accessibility, and the evolution of telemedicine and digital health. Key trends to watch during this period include pharmacogenetic testing, advancements in genomic technologies, technological progress, developments in companion diagnostics, and innovative diagnostic exams.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Are The Contributors To Demand In The Pediatric Vaccine Market?

The pediatric vaccines market is set to expand due to the increasing occurrence of chronic illnesses such as tuberculosis, diphtheria, and pneumonia in children aged 15 years and younger. Infectious diseases pose a greater threat of severe consequences and complications in children and teenagers who suffer from chronic conditions. As per the Australian Bureau of Statistics, a self-sufficient statutory agency in Australia responsible for collecting and assessing data, making factual suggestions, roughly 46.6% (equating to 11.6 million) of the total population had at least one chronic condition as of March 2022. The growing incidence of chronic illnesses in children enhances the necessity for protection from these diseases through immunization, thereby propelling the steady growth of the pediatric vaccine market.

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Long-Term Trends Are Likely To Affect The Pediatric Vaccine Market?

Top businesses engaged in the pharmacogenetics testing market are introducing innovative pharmacogenomics testing solutions, such as those based on prescriptions, in order to stay competitive. Prescription-oriented pharmacogenetic testing involves genetic assessments ordered by healthcare practitioners to understand a patient’s genetic structure before prescribing medicines. For instance, in May 2023, UCSF, a healthcare firm based in the United States, rolled out its pharmacogenomics testing service. This service has been developed to heighten the accuracy of medical treatments. The pharmacogenomics testing service offered by UCSF enables healthcare professionals to customize drug therapies centered on a patient’s distinct genetic makeup. The goal is to boost the effectiveness of drugs, reduce unwanted side effects, and promote personalized medicine approaches.

Who Are The Top-Ranked Companies In The Pediatric Vaccine Market Today?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

How Is Pediatric Vaccine Market Adoption Varying Across Different Regions And Sectors?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Pharmacogenetic Testing Market From 2025 To 2029?

The market size for pharmacogenetic testing has seen a swift expansion in recent years. It’s projected to escalate from $12.37 billion in 2024 to $14.33 billion in 2025, marking a compound annual growth rate (CAGR) of 15.8%. The historical growth trajectory is linked to several factors including an increase in overall drug effectiveness, rising acceptance of personalized medicine, a growing requirement for precision diagnosis, amplified focus on pharmacogenetic testing, and an enhancement in medical expenditure.

The market size for pharmacogenetic testing is projected to experience a significant expansion in the coming years, reaching $25.62 billion by 2029 with an annual compound growth rate of 15.6%. This growth in the projected period can be credited to factors such as increased biotechnology and healthcare research and development, rising healthcare expenses, growing prevalence of chronic diseases, improvements in accessibility, and the growth of telemedicine and digital health. Key trends anticipated during this forecast period involve pharmacogenetic testing, evolution in genomic technologies, technological progression, advancements in companion diagnostics, and groundbreaking diagnostic testing methods.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

Which Primay Drivers Are Accelerating Growth in the Pharmacogenetic Testing Market?

The surge in demand for personalized medicine is projected to boost the expansion of the pharmacogenetic testing market. Personalized medicine, alternatively known as precision medicine, is a medical model that customizes healthcare choices and treatments based on the unique traits of each patient. The rise in personalized medicine is attributed to factors such as enhanced treatment results, prioritization on early detection and prevention, and cost-efficiency. Pharmacogenetic testing plays a vital role in personalized medicine by examining a person’s genetic composition to anticipate their reaction to specific medications. This allows healthcare professionals to adjust treatments based on genetic variations, maximizing drug effectiveness and reducing harmful side effects. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, stated that the FDA approved 16 innovative personalized treatments for patients with rare diseases in 2023, in contrast to six in 2022. Therefore, the escalating demand for personalized medicine is fueling the development of the pharmacogenetic testing market.

Which Primary Segments of the Pharmacogenetic Testing Market Are Driving Growth and Industry Transformations?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Pharmacogenetic Testing Market?# Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Pharmacogenetic Testing Industry Dynamics?

Key players in the pharmacogenetics testing market are focusing on the creation of advanced pharmacogenomic testing solutions, such as prescription-driven pharmacogenetic testing, to secure a dominant position in the market. Prescription-dependent pharmacogenetic testing is a type of genetic testing that health professionals order specifically to examine a patient’s genetic structure prior to prescribing drugs. For example, in May 2023, the American healthcare firm UCSF launched its own pharmacogenomics testing service crafted to optimize the accuracy of medical therapies. The pharmacogenomics testing service offered by UCSF enables medical practitioners to customize drug treatments based on a person’s genetic makeup, with the goal of increasing drug effectiveness, reducing negative side effects, and bolstering personalized medicine approaches.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

What Parameters Are Used to Define the Pharmacogenetic Testing Market?

Pharmacogenetic testing is a type of genetic testing that examines how an individual’s genetic makeup influences their response to specific medications, helping to tailor drug treatments for better efficacy and reduced side effects. This personalized approach enhances patient care by tailoring therapies based on genetic profiles. It is widely used in fields such as oncology, psychology, and cardiology.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19139

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model